【参考文献】 1 Atanackovic D,Arfsten J,Cao Y,et al.Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.Blood,2007,109:1103-1112. 2 Matsui W,Huff CA,Wang Q,et al.Characterization of clonogenic multiple myeloma cells.Blood,2004,103:2332-2336. 3 Bataille R,Harousseau JL.Multiple myeloma.N Engl J Med,1997,336:1657-1664. 4 Collins CD.Multiple myeloma.Cancer Imaging,2004,4:S47-S53. 5 全昌斌,贾树林,孙德清.典型及不典型多发性骨髓瘤40例X线分析.中国医学影像技术,1999,15(6):429. 6 Rajkumar SV,Gertz MA,Kyle RA,et al.Current therapy for multiple myeloma.Mayo Clin Proc,2002,77:813-822. 7 San Miguel JF,García-Sanz R.Prognostic features of multiple myeloma.Best Practice & Research Clinical Haematology,2005,18(4):569-583. 8 陈仲武,陈益光,李跃明.多发性骨髓瘤的临床及影像分析.中国临床医学影像杂志,2004,15(1):35-37. 9 Johnson RJ,Feehally J.Comprehensive clinical nephrology.2nd ed.Mosby:Edinburgh,2003,235-240. 10 Grogan TM,Spier CM.The B cell immunoproliferative disorders including multiple myeloma and amyloidosis.In:Knowles DM,editor.Neoplastic haematopathology.2nd ed.Philadelphia: Lippincott Williams and Wilkins,2001,1557-1587. 11 姜鸥,许卫.颅骨平片对多发性骨髓瘤诊断的价值.中国医学影像技术,1999,15(10):761. 12 Horger M,Kanz L,Denecke B,et al.The benefit of using whole-body,low-dose,nonenhanced,multidetector computed tomography for follow up and therapy response monitoring in patients with multiple myeloma.Cancer,2007,109:1617-1626. 13 Baur-Melnyk A,Buhmann S,Durr HR,et al.Role of MRI for the diagnosis and prognosis of multiple myeloma.Eur J Radiol,2005,55:56-63. 14 张华,潘自来,江浩,等.多发性骨髓瘤的MRI表现.中国医学影像技术,1999,15(7):563-565. 15 龙莉玲,宋英儒,黄仲奎.多发性骨髓瘤的MRI和X线诊断价值.临床放射学杂志,2001,20(9):696-698. 16 Laura R,Cibeira MT,Uriburu C,et al.Bortezomib:an effective agent in extramedullary disease in multiple myeloma.Eur J Haematol,2006,76:405-408. 17 王丽萍,徐文坚.多发性骨髓瘤的MRI表现与临床特点相关性的研究进展.山东医药,2006,46(17):90-91. 18 武永吉,李剑.浆细胞病及其研究进展.中国实用内科杂志,2007,27(19):1491-1496. 19 王淑娟,朱立华.多发性骨髓瘤及其实验室诊断.中华检验医学杂志,2004,27(4):255-258. |
|